HAP Trading, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$37,017
+61595.0%
24,600
-52.6%
0.01%
-33.3%
Q1 2023$60
-60.3%
51,900
+339.8%
0.01%
-40.0%
Q4 2022$151
-99.6%
11,800
-7.1%
0.02%
+650.0%
Q2 2022$36,000
-43.8%
12,700
-33.9%
0.00%
-33.3%
Q1 2022$64,000
-77.1%
19,200
-52.5%
0.00%
-62.5%
Q4 2021$280,000
-16.4%
40,400
-17.7%
0.01%
-20.0%
Q3 2021$335,000
+544.2%
49,100
+187.1%
0.01%
+400.0%
Q2 2021$52,000
-95.0%
17,100
-73.5%
0.00%
-96.4%
Q1 2021$1,050,000
-63.2%
64,582
-3.8%
0.06%
-31.7%
Q4 2020$2,850,000
+707.4%
67,123
+28.8%
0.08%
+382.4%
Q3 2020$353,000
-64.9%
52,100
-14.9%
0.02%
-69.1%
Q2 2020$1,006,000
-36.4%
61,200
-62.5%
0.06%
-36.8%
Q4 2019$1,583,000
+433.0%
163,300
+279.8%
0.09%
+262.5%
Q3 2019$297,000
-96.7%
43,000
-89.7%
0.02%
-96.5%
Q2 2019$9,045,000
+2537.0%
417,166
+275.8%
0.70%
+2141.9%
Q1 2019$343,000
-83.4%
111,000
+68.7%
0.03%
-76.2%
Q4 2018$2,065,000
-46.1%
65,794
-7.1%
0.13%
-46.3%
Q3 2018$3,829,000
+109.6%
70,803
+2.9%
0.24%
+163.0%
Q2 2018$1,827,000
+559.6%
68,800
+69.0%
0.09%
+557.1%
Q1 2018$277,000
+42.1%
40,700
+2.0%
0.01%
+75.0%
Q4 2017$195,000
+84.0%
39,900
+59.6%
0.01%
+60.0%
Q3 2017$106,000
-95.1%
25,000
-82.1%
0.01%
-95.4%
Q4 2016$2,177,000
+36.3%
139,356
-50.5%
0.11%
+94.6%
Q3 2016$1,597,000
-2.5%
281,700
-31.6%
0.06%
-41.7%
Q2 2016$1,638,000
+6725.0%
411,900
+2906.6%
0.10%
+4700.0%
Q1 2016$24,000
-95.3%
13,700
-80.4%
0.00%
-92.0%
Q4 2015$515,000
+2929.4%
69,800
+571.2%
0.02%
+2400.0%
Q3 2015$17,000
-99.1%
10,400
-98.0%
0.00%
-99.1%
Q2 2015$1,818,000
+2613.4%
510,000
+434.0%
0.11%
+5400.0%
Q2 2014$67,000
-85.7%
95,500
-6.2%
0.00%
-86.7%
Q4 2013$468,000
-20.1%
101,800
+69.9%
0.02%
-21.1%
Q3 2013$586,000
-82.6%
59,900
-83.1%
0.02%
-83.3%
Q2 2013$3,374,000355,4190.11%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders